ABL1 and cancer: In the present study, we show that the natural diterpenoid compound oridonin, which acts through posing oxidative stress in cancer cells, activates HSF1 and HSP70 and targets BCR-ABL for ubiquitin-proteasome degradation (Fig. 7).